0 %

LAMP Human PAI-1 mutation KIT

The LAMP Human PAI-1 mutation KIT is an in vitro diagnostic test intended for the qualitative detection of PAI-1 insertion/deletion (5G/4G) by Loop-mediated isothermal amplification (LAMP) on EDTA whole blood and extracted DNA. This assay is dedicated to professional use in diagnostic laboratories. The device is not for self-testing.

Regulatory Status: CE-IVD

Format: 24 reactions 

Target gene: PAI-1

Linked disease: Thrombophilia 

Method: LAMP + meting curve analysis 

Sample: EDTA whole blood - no DNA extraction required - or extracted DNA

Compatible instruments: LightCycler 480 I&II / Cobas z 480 (Roche); CFX96 / CFX Opus 96 (Bio-Rad); QuantStudio 1/3/5 & 6/7 Flex (Applied Biosystems); MIC qPCR (Bio Molecular Systems); LC-Genie III & Genie HT (Optigene)

Software / result interpretation: Automated genotype calling via GeneFox software; mandatory visual confirmation of the melting curve

Turn around time: < 1h 

General information

Advantages

icon fast
Fast
icon No-DNA-extraction
No DNA extraction
icon comprehensive
Compatible with a variety of qPCR machines
icon easy-to-use
Automatic interpretation of the results

Linked products

LaCar
The LAMP Human Prothrombin mutation KIT is an in vitro diagnostic test intended for the qualitative detection of Factor II G20210A by Loop-mediated isothermal amplification (LAMP) on EDTA whole blood and extracted DNA.
LaCar
The LAMP Human FV LEIDEN mutation KIT is an in vitro diagnostic test intended for the qualitative detection of Factor V Leiden G1691A by Loop-mediated isothermal amplification (LAMP) on EDTA whole blood and extracted DNA.
LaCar
The LAMP Human FII&FVL duplex KIT is an in vitro diagnostic test intended for the qualitative detection of the Factor II G20210A and the Factor V Leiden G1691A polymorphisms by Loop-mediated isothermal amplification (LAMP) on EDTA whole blood and extracted DNA.
Software that helps to interpret the results of LaCAR GPD and pharmacogenetics assays and generates standardised reports.

The assay uses loop mediated isothermal amplification, a robust amplification method using four to six primers per target, that can be directly used on lysed EDTA-whole blood sample, without DNA purification and on extracted DNA samples from whole blood samples.


The genotyping is performed by melting curve analysis after amplification, using a specific probe and quencher for each target SNP.

Test principle

A common single nucleotide insertion/deletion (5G/4G) in the promotor region of the plasminogen activator inhibitor-1 (PAI-1) gene results in higher levels of PAI-1 in the serum. Since PAI-1 indirectly inhibits the breakdown of blood clots, heterozygous or homozygous carriers of this mutation have an increased risk of venous thrombosis, particularly when other relevant thrombosis-related mutations are present simultaneously.

Background Information

You have a question regarding our products ? You want to know more about our method ?

Find out about our other expertises

Genetic testing CE Kits
Newborn Screening
Genetic testing CE Kits
Pharmacogenetics
Contact